-
The Sherer Report: April 2012
April 19, 2012
… Sherer Report,” my continuing series of updates on progress from the front lines of Parkinson’s research, I’m … are pursuing innovative approaches that come directly from our increased understanding of PD over the past 10 … delivery of levodopa could help patients get more benefit from their therapy with less risk of side effects. Two MJFF …
-
A Busy Weekend for Team Fox!
September 17, 2012
… dozen griddle teams will take their turn flipping pancakes from 8 a.m. to noon. Learn more on their Team Fox page . … ! She is not letting her Parkinson’s diagnosis stop her from crossing the finish line. Good luck, Katie! SUNDAY, … upcoming Boston Cup Classic Car Show. Stop by Boston Common from 9 a.m. to 2 p.m. to check out some concours quality …
-
John Q. Trojanowski, MD, PhD
… Dr. Trojanowski obtained his MD/PhD in 1976 from Tufts University in Boston. After a medicine internship … awards for his research including a MERIT Award (1986-1994) from the National Institutes of Health (NIH), the … and 'Genetics of Alzheimer's Disease (March, 2002) workshops organized by NIA and the National Institute on …
-
Roger Long: A Tale of Two Summits
July 7, 2012
… We're pleased to shared this guest post from Team Fox member Roger Long.. Below, Roger brings us up … to scale Mt. Kilimanjaro and shares a serendipitous moment from the top of Mt. Bierstadt in Colorado. The gear is … first person I saw was a man named Mark, who had traveled from Michigan to climb Mt. Bierstadt with a family member. …
-
Tour de Fox Pacific Northwest: Cyclists Make Headway toward a Cure
August 23, 2016
… 75-mile ride as part of Team "For Pete's Sake." Val Swanell from West Vancouver, diagnosed with Parkinson's in 2010, participated in the 35-mile ride with support from her brother Geoffrey. And longtime Team Fox member Jimmy Choi traveled from Illinois to participate in the ride while his wife …
-
Another Leap Forward for LRRK2 Development
August 25, 2016
… today announced it has licensed LRRK2 inhibitor compounds from Genentech. These drug candidates may address the … was formerly at Genentech and led a study with co-authors from MJFF that found the company's LRRK2 inhibitors were … we announced that while the changes are seen in compounds from each company, they are reversible and not associated …